SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IPIC
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
1359 13 0 IPIC
Emcee:  David D. Long Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
509 Wild ride today on IPIC. Looks like we have a little resistence at the 21 levecoop-8/6/1997
508 Hi everyone, This is Margaret peeking in to IPIC from the dungeon where she margaret foley-8/6/1997
507 I have a feeling from reading the DLJ summary that citicoline is the whole ballThomas C. White-8/5/1997
506 It is scary to be optimistic because of my huge losses but I am thinking, thinkJanet Madison-8/5/1997
505 IPIC pounding this morning, up more than $1 on good volume. Is this due to resThomas C. White-8/5/1997
504 IPIC is a strong buy on any weakness below 17-1/2. ie, it's time to start P.Prazeres-8/4/1997
503 Here's a statment by the American Obesity Association about phen-fen: prneBiomaven-8/4/1997
502 I heard from Vicki once awhile ago and it sounded like she was doing well! I ternie de la fuente-7/30/1997
501 Ernie, Still alot of resistance in the low 20's. I'm with some of theP.Prazeres-7/30/1997
500 Earlier I posted that the phen/fen problems might be neutral for Redux because Biomaven-7/28/1997
499 <b>ERNESTO DE LA FUENTE BAD CALLSThey played this before on your advice &Shogun-7/28/1997
498 Hey Paulo, Vicki This is a trader again!! Looks like IPIC is back to its cycleernie de la fuente-7/27/1997
497 Donaldson, Lufkin and Jenrette analyst Alex To said he initiated coverage of INKen Kuly-7/22/1997
496 DLJ started coverage. Big firm, many clients, much money. Should help this Arthur S. Conroy-7/22/1997
495 I just heard a blurb on CNBC that some brokerage house just began coverage of IScott Pratho-7/22/1997
494 Charles - A synopsis of the study is available in an 8-K filed with the SEC. Biomaven-7/17/1997
493 1) If you are referring to the full 6 page press release, some or all of it wasNeuroInvestment-7/17/1997
492 NI, Thanks for your insight/response. You are right about the CYA prescribing. Scott Pratho-7/16/1997
491 Outstanding analysis, much appreciated. How does one get a synopsis of or actucharles feicht-7/16/1997
490 I was just preparing some comments on citicoline developments, so here they areNeuroInvestment-7/16/1997
489 Neuro-investment, please weigh in here on the results of Phase III, their signicharles feicht-7/16/1997
488 The market for this drug is huge. All brain injured patients or potentially brcharles feicht-7/16/1997
487 This is huge, huge, HUGE. There is only one other treatment for stroke and it iScott Pratho-7/16/1997
486 This is huge. Lehman has revnue estimates of citocoline as follows: 13.8M in 1Hong-Lee Yu-7/15/1997
485 NEWS! biz.yahoo.com Isn't it disgusting how this stock is suurounded by nernie de la fuente-7/15/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):